XWELL, Inc. — Form 8-K
Filed October 7, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
XWELL filed form documents for XpresTest, Inc. (a subsidiary) executing a stock repurchase agreement with an unnamed seller, whereby XpresTest repurchases restricted common stock ("Awarded Shares") at an unspecified purchase price (dollar amount and share count left blank in template). The transaction is expressly contingent on closing of a concurrent Securities Purchase Agreement dated July 6, 2026 among XWELL, Inc., XpresSpa Holdings, LLC, XpresTest, Inc., and Express Wellness Group, LLC. The repurchase triggers full vesting of any unvested shares and requires the seller to release all claims against the company and its affiliates.
Why this rating
Template form with material terms (price, shares, seller identity, dates) left blank; contingent on undisclosed Securities Purchase Agreement; no quantified impact on $3.6M market cap disclosed.
See more from October 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.